Schlumberger (SLB) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.37%. A quarter ago, it was expected that this world's largest oilfield services company would post earnings of $0.74 per share when it actually produced earnings of $0.72, delivering a surprise of -2.7%.Over the las ...

Blackboxstocks Provides Stockholder Update on Acquisition of Rare Earth Company Blackboxstocks, Inc. Stockholder UpdateDALLAS, July 18, 2025 – PRISM MediaWire – Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox”), a financial technology and social media hybrid platform, today released a stockholder update from CEO Gust Kepler:As we kick off the first month of Q3 2025, I’m excited to update our stakeholders on our developments, especially with respect to our foray into the rare earth sector with our pending acq ...

Core Insights - Trump Media and Technology Group Corp. has launched a customized Truth Social app for iPad devices, enhancing user experience on iPad screens and improving interaction with the Truth+ platform [1][2] - The Truth Social and Truth+ apps are available on various platforms, including iOS, Android, and web, as well as on smart TVs [3] - Trump Media aims to provide a platform for free speech and is expanding its services with Truth.Fi, a financial services and FinTech brand [5] Group 1 - The Truth Social app is specifically designed for iPadOS to optimize layout and enhance cross-platform interaction [2] - The company plans to continuously test and update the app based on user feedback [2] - Truth Social and Truth+ are accessible on multiple devices, including Apple TVs and Android TVs [3] Group 2 - Trump Media's mission is to counteract perceived censorship by Big Tech and promote free expression [5] - The company is also launching Truth.Fi, which focuses on America First investment vehicles [5]

统计显示，成交金额最多的是海天瑞声，共有9笔大宗交易，合计成交量为38.30万股，成交金额合计 3830.00万元；其次是光云科技、富创精密，今日大宗交易金额分别为2491.62万元、2093.60万元。 证券时报·数据宝统计显示，7月18日共有16只科创板股发生大宗交易，合计成交31笔，累计成交量 483.67万股，成交额合计1.71亿元。 16只科创板股大宗交易平台今日发生交易，合计成交1.71亿元。 | 代码 | 简称 | 成交笔 | 大宗交易数量 | 平均成交价格 | 相对收盘价折溢价 | 大宗交易金额 | | --- | --- | --- | --- | --- | --- | --- | | | | 数 | （万股） | （元） | （%） | （万元） | | 688787 | 海天瑞 声 | 9 | 38.30 | 100.00 | -14.75 | 3830.00 | | 688365 | 光云科 技 | 7 | 172.43 | 14.45 | -14.95 | 2491.62 | | 688409 | 富创精 | 2 | 40.00 | 52.34 | -0.49 | 2093.60 ...

证券代码：300839 证券简称：博汇股份 公告编号：2025-101 本次购买资产系公司战略布局智能算力服务新业务的重要一步，将有力推 动公司在算力服务领域的快速发展。通过本次购买资产及开展新业务，子公司 能够加速构建自身的 AI 算力资源，搭建高效、稳定的算力服务平台，为 AI 算 力相关业务提供强有力的技术支撑。本次购买资产成交金额为参照市场价格并 经双方协商确认，价格合理、公允，不存在影响公司及全体股东利益的情形。 同意全资子公司无锡极致液冷科技有限公司购买资产并用于开展智能算力服务 及相关业务，采购总金额预计不超过人民币 3.9 亿元。 具体内容详见公司同日披露于巨潮资讯网的《关于子公司购买资产的公告》 （公告编号：2025-102）。 表决结果：3 票同意，0 票反对，0 票弃权。 债券代码：123156 债券简称：博汇转债 宁波博汇化工科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 宁波博汇化工科技股份有限公司（以下简称"公司"）第四届监事会第十九 次会议于近日以现场方式在公司会议室召开，会议通过口头及电 ...

Back in early October of last year, I decided to revisit Select Medical Holdings Corporation (NYSE: SEM ), one of the largest operators of critical centers, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the US. ICrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock ...

Ally Financial shares rose after the lender reported strong consumer auto-loan originations and earnings that topped analysts’ expectations https://t.co/DJuRn3iLzr ...

Core Viewpoint - Netflix stock has nearly doubled over the last 12 months, currently trading around $1,270, driven by initiatives like password sharing crackdown and the expansion of advertising-supported streaming [1][6] - Despite strong Q2 results with a 16% revenue growth, there are concerns about potential downside risks due to macroeconomic uncertainties and slowing subscriber growth [1][5] Group 1: Financial Performance - In 2024, Netflix added over 40 million subscribers, reaching nearly 302 million paid users, significantly contributing to the stock's rally [6] - The company's Q2 earnings showed improved margins, but there are warnings that operating margins could trend lower in the second half of 2025 due to rising content amortization and marketing costs [8][7] - Netflix's current stock price reflects a valuation of around 50 times consensus 2025 earnings, which is considered expensive compared to a valuation of about 20 times earnings in mid-2022 [11] Group 2: Subscriber Growth and Market Dynamics - Key initiatives like the password-sharing crackdown and ad-supported plans have been rolled out, but these may have pulled forward demand, leading to potential slower subscriber additions in the future [5][6] - The decision to stop reporting subscriber numbers starting in 2025 may indicate internal expectations of slower growth [5] - Economic factors such as inflation and rising costs could negatively impact consumer spending, which is crucial for Netflix's subscription model [7] Group 3: Historical Context and Volatility - Historical data shows that Netflix stock has experienced significant declines in past downturns, including a 75.9% drop from November 2021 to May 2022 [10] - The stock has shown resilience during downturns, performing slightly better than the S&P 500 in some cases [9] - The potential for a 50% to 60% correction from current levels is highlighted as a possibility based on historical performance [1][2]

India’s National Securities Depository plans to start taking investor orders as early as next week for its initial public offering, which could raise as much as $500 million, sources say https://t.co/fnZ105oVlz ...

Core Insights - Fangzhou Inc. has signed a Memorandum of Understanding with Novo Nordisk to collaborate on managing chronic diseases like diabetes and obesity using AI and innovative healthcare solutions [1][3][4] Company Overview - Fangzhou Inc. is a leading online chronic disease management platform in China, with 49.2 million registered users and 223,000 physicians as of December 31, 2024 [5] Collaboration Details - The partnership aims to leverage Novo Nordisk's expertise in diabetes and obesity treatment alongside Fangzhou's smart healthcare ecosystem to create a comprehensive health management service [3][4] - The collaboration will focus on medication guidance, reminders, efficacy tracking, and health education, shifting from a "disease-centered" to a "health-centered" model [3][4] Future Goals - Both companies aim to enhance public awareness of diabetes and obesity and implement early screening, diagnosis, and treatment within smart healthcare environments [4] - The partnership is expected to explore further innovative collaborations in the digital transformation of the medical industry, contributing to the "Healthy China 2030" strategic objectives [4]